SEEDLINK

Biospectal Raises $4.3M Seed Funding Led by Digital Health Investor, SeedLink

Retrieved on: 
Wednesday, July 21, 2021

Remote patient monitoring and biosensing company will use investment to scale its OptiBP™ blood pressure measurement and monitoring product and operations worldwide; Renowned interventional cardiologist and inventor, Dr. Fred St. Goar, MD and SeedLink's Tim Juergens appointed to Biospectal's Board of Directors

Key Points: 
  • Biospectal will leverage the new funds to scale its OptiBPsmartphone blood pressure monitoring application and data platform technology worldwide.
  • Biospectal OptiBP for iOS is currently in alpha and is planned for public beta launch in the second half of 2021.
  • OptiBP's data also connects seamlessly with clinicians to support treatment regimens that help improve health and quality of life.
  • SeedLink SL supports founders in successfully establishing and growing solutions in the Digital Health space, with special focus on Digital Therapeutics (DtX), Digital Biomarkers, and platform-based business models.

Biospectal Raises $4.3M Seed Funding Led by Digital Health Investor, SeedLink

Retrieved on: 
Wednesday, July 21, 2021

LAUSANNE, Switzerland and SAN FRANCISCO, July 21, 2021 /PRNewswire/ -- Biospectal SA, the remote patient monitoring and biosensing software company, today announced the closing of a $4.3M (€3.7M Euros) round of seed funding led by digital health investor, SeedLink, with additional funding from LabCorp, Athensmed, Swiss based Privilege Ventures and other European and US investors. Biospectal will leverage the new funds to scale its OptiBP™ smartphone blood pressure monitoring application and data platform technology worldwide. Biospectal OptiBP for Android launched in public beta in January 2021. Biospectal OptiBP for iOS is currently in alpha and is planned for public beta launch in the second half of 2021. View a short video of how Biospectal OptiBP works here.

Key Points: 
  • Biospectal will leverage the new funds to scale its OptiBPsmartphone blood pressure monitoring application and data platform technology worldwide.
  • Biospectal OptiBP for iOS is currently in alpha and is planned for public beta launch in the second half of 2021.
  • OptiBP's data also connects seamlessly with clinicians to support treatment regimens that help improve health and quality of life.
  • SeedLink SL supports founders in successfully establishing and growing solutions in the Digital Health space, with special focus on Digital Therapeutics (DtX), Digital Biomarkers, and platform-based business models.

An innovative partnership to give Africa's Farmers access to zero carbon irrigation technologies enabling them to increase yields and raise farmers' incomes by serving local and international markets

Retrieved on: 
Wednesday, October 16, 2019

The Partnership will increase employment and climate resilience for communities while allowing western consumers to support a sustainable increase of farmers' incomes across Africa.

Key Points: 
  • The Partnership will increase employment and climate resilience for communities while allowing western consumers to support a sustainable increase of farmers' incomes across Africa.
  • Phil Selwyn, Technical Director, Water Powered Technologies Ltd.
    SEEDLINK Ltd. is already working with 1000's of small holder farmers trialling new crops for local and international markets to support a sustainable increase of crop yields.
  • Seedlink also help multi-national buyers source crops direct from smallholders, often paying higher prices than the local markets.
  • "Africa's farmers can rapidly increase yields for many crops with zero carbon irrigation while not suffering from increasing fuel costs which limit their incomes.